USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE

David Bernhard; Marina Müller

USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE

David Bernhard (Erfinder*in)
, Marina Müller (Erfinder*in)

Publikation: Patent (Schutzrecht) › Patent

Abstract

The present invention provides for leoligin or a derivative thereof for use in the prevention and/or reduction of tissue damages, wherein leoligin or the derivative thereof is administered systemically to the subject in need thereof.

Originalsprache	Englisch
Veröffentlichungsnummer	US12564570
Publikationsstatus	Veröffentlicht - 03 März 2026

Wissenschaftszweige

301109 Pathophysiologie
301110 Physiologie

Zugriff auf Dokument

https://worldwide.espacenet.com/patent/search/family/072290857/publication/US12564570B2?q=US12564570

Andere Dateien und Links

https://patents.google.com/patent/US7888998B1/en?oq=US12564570

Dieses zitieren

@misc{28f301cb34e543ffa139c49fa9f406b7,

title = "USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE",

abstract = "The present invention provides for leoligin or a derivative thereof for use in the prevention and/or reduction of tissue damages, wherein leoligin or the derivative thereof is administered systemically to the subject in need thereof.",

author = "David Bernhard and Marina M{\"u}ller",

note = "JKU19015 JKU Status: Patent aufrecht; US12564570",

year = "2026",

month = mar,

day = "3",

language = "English",

publisher = "U.S. Patent and Trademark Office (USPTO)",

type = "Patent",

}

TY - PAT

T1 - USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE

AU - Bernhard, David

AU - Müller, Marina

N1 - JKU19015 JKU Status: Patent aufrecht

PY - 2026/3/3

Y1 - 2026/3/3

N2 - The present invention provides for leoligin or a derivative thereof for use in the prevention and/or reduction of tissue damages, wherein leoligin or the derivative thereof is administered systemically to the subject in need thereof.

AB - The present invention provides for leoligin or a derivative thereof for use in the prevention and/or reduction of tissue damages, wherein leoligin or the derivative thereof is administered systemically to the subject in need thereof.

UR - https://patents.google.com/patent/US7888998B1/en?oq=US12564570

M3 - Patent

M1 - US12564570

PB - U.S. Patent and Trademark Office (USPTO)

ER -